UB Paderborn / Katalog / Suche / in CDI

1 – 8 von 8

Sortiert nach

US Antiarrhythmic Drug Treatment for Patients With Atrial Fibrillation: An Insurance Claims-Based Report

Journal of the American Heart Association, 2021-03, Vol.10 (6), p.e016792-e016792

2021

Volltextzugriff (PDF)

Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States

American journal of preventive cardiology, 2020-03, Vol.1, p.100010-100010, Article 100010

2020

Volltextzugriff (PDF)

Erratum to ‘Lipid Treatment and Goal Attainment Characteristics among Persons with Atherosclerotic Cardiovascular Disease in the United States’ [American Journal of Preventive Cardiology 1C (2020) 100010]

American journal of preventive cardiology, 2021-03, Vol.5, p.100160-100160, Article 100160

2021

Volltextzugriff (PDF)

Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2020-06, Vol.20 (3), p.239-248

2020

Volltextzugriff (PDF)

Cost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurrence: a US payer perspective

Journal of medical economics, 2024, Vol.27 (1), p.543-553

2024

Volltextzugriff (PDF)

Challenges, considerations, and approaches for developing a cost-effectiveness model for the adjuvant treatment of muscle-invasive urothelial carcinoma: with a spotlight on nivolumab versus placebo

Journal of medical economics, 2024, Vol.27 (1), p.473-481

2024

Volltextzugriff (PDF)

Comparison of costs incurred by patients treated with adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.500-500

2023

Volltextzugriff (PDF)

Burden, Control, and Treatment of Moderate to Severe Atopic Dermatitis in 2021: A United States Patient Survey Study

Journal of drugs in dermatology, 2023-02, Vol.22 (2), p.119

2023

Volltextzugriff (PDF)

1 – 8 von 8

Suche als RSS-Feed

Aktive Filter

ThemaCancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(7)
Mit Volltextzugriff
(7)

Publikationsform

Artikel
(8)

Sprache

Englisch
(8)

Erscheinungsjahr

n.n

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

US Antiarrhythmic Drug Treatment for Patients With Atrial Fibrillation: An Insurance Claims-Based Report

Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States

Erratum to ‘Lipid Treatment and Goal Attainment Characteristics among Persons with Atherosclerotic Cardiovascular Disease in the United States’ [American Journal of Preventive Cardiology 1C (2020) 100010]

Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses

Cost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurrence: a US payer perspective

Challenges, considerations, and approaches for developing a cost-effectiveness model for the adjuvant treatment of muscle-invasive urothelial carcinoma: with a spotlight on nivolumab versus placebo

Comparison of costs incurred by patients treated with adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma

Burden, Control, and Treatment of Moderate to Severe Atopic Dermatitis in 2021: A United States Patient Survey Study

Aktive Filter

Suchergebnisse filtern